P2: Snp Analysis in Brca Positive and Brca Negative Subjects with and without Breast Cancer (Brca) Reveal Central Role of Alk Snps and Tgfbeta Superfamily in Malignant Transformation
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido
Journal of Investigative Medicine 64(3): 817.3-818
2016
ISSN/ISBN: 1081-5589
DOI: 10.1136/jim-2016-000080.42
Accession: 067672975
PDF emailed within 0-6 h: $19.90
Related References
Verma, S.; Dent, S.F.; Paquet, L.; Bitonti, L. 2016: When the BRCA test is negative-Prevention strategies in women who have no detectable mutation (BRCA-) compared to women harboring positive BRCA mutations (BRCA+) Journal of Clinical Oncology 26(15_Suppl): 1534-1534Lee, C.Khoon.; Scott, C.; Lindeman, G.J.; Hamilton, A.; Lieschke, E.; Gibbs, E.; Asher, R.; Badger, H.; Paterson, R.; Macnab, L.; Kwan, E.Michael.; Francis, P.A.; Boyle, F.; Friedlander, M. 2019: Phase 1 trial of olaparib and oral cyclophosphamide in BRCA breast cancer, recurrent BRCA ovarian cancer, non-BRCA triple-negative breast cancer, and non-BRCA ovarian cancer British Journal of Cancer 120(3): 279-285
Bremer, M.; Steinmann, D.; Dork, T.; Borger, J.; Rades, D.; Karstens, J.H. 2001: Bilaterales Mammakarzinom und Lokalrezidiv: Prävalenz von BRCA-1- und BRCA-2-Genmutationen an einem unselektionierten Kollektiv - Bilateral breast cancer and local relapse: a hospital-based study of the prevalence of BRCA 1 and BRCA 2 gene Mutations Strahlentherapie und Onkologie 177(7): 325-329
Atchley, D.P.; Albarracin, C.T.; Lopez, A.; Valero, V.; Amos, C.I.; Gonzalez-Angulo, A.M.; Hortobagyi, G.N.; Arun, B.K. 2008: Clinical and pathologic characteristics of patients with BRCA-positive and BRCA-negative breast cancer Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 26(26): 4282-4288
Comen, E.A.; Robson, M.E. 2009: Clinical and Pathologic Characteristics of Patients With BRCA-Positive and BRCA-Negative Breast Cancer Breast Diseases: A Year Book Quarterly 20(2): 145-146
Webb, E. 2014: BRCA-negative women from BRCA-positive families may still be at increased risk of developing breast cancer Pharmacogenomics 15(3): 258-259
Triantafyllidou, O.; Vlachos, I.S.; Apostolou, P.; Konstantopoulou, I.; Grivas, A.; Panopoulos, C.; Dimitrakakis, C.; Kassanos, D.; Loghis, C.; Bramis, I.; Vlahos, N.; Yannoukakos, D.; Fostira, F. 2015: Epidemiological and clinicopathological characteristics of BRCA-positive and BRCA-negative breast cancer patients in Greece Journal of BUON: Official Journal of the Balkan Union of Oncology 20(4): 978-984
Huang, X.; Shao, D.; Wu, H.; Zhu, C.; Guo, D.; Zhou, Y.; Chen, C.; Lin, Y.; Lu, T.; Zhao, B.; Wang, C.; Sun, Q. 2020: Genomic Profiling Comparison of Germline BRCA and Non-BRCA Carriers Reveals CCNE1 Amplification as a Risk Factor for Non-BRCA Carriers in Patients with Triple-Negative Breast Cancer Frontiers in Oncology 10: 583314
Ottini, L.; Silvestri, V.; Rizzolo, P.; Falchetti, M.; Zanna, I.; Saieva, C.; Masala, G.; Bianchi, S.; Manoukian, S.; Barile, M.; Peterlongo, P.; Varesco, L.; Tommasi, S.; Russo, A.; Giannini, G.; Cortesi, L.; Viel, A.; Montagna, M.; Radice, P.; Palli, D. 2012: Clinical and pathologic characteristics of BRCA-positive and BRCA-negative male breast cancer patients: results from a collaborative multicenter study in Italy Breast Cancer Research and Treatment 134(1): 411-418
Katki, H.A.; Gail, M.H.; Greene, M.H. 2007: Breast-cancer risk in BRCA-mutation-negative women from BRCA-mutation-positive families LANCET. Oncology 8(12): 1042-1043
Bakos, A.D.; Hutson, S.P.; Loud, J.T.; Peters, J.A.; Giusti, R.M.; Greene, M.H. 2008: BRCA mutation-negative women from hereditary breast and ovarian cancer families: a qualitative study of the BRCA-negative experience Health Expectations: An International Journal of Public Participation in Health Care and Health Policy 11(3): 220-231
Karginova, O.; Siegel, M.B.; Van Swearingen, A.E.D.; Deal, A.M.; Adamo, B.; Sambade, M.J.; Bazyar, S.; Nikolaishvili-Feinberg, N.; Bash, R.; O'Neal, S.; Sandison, K.; Parker, J.S.; Santos, C.; Darr, D.; Zamboni, W.; Lee, Y.Z.; Miller, C.R.; Anders, C.K. 2015: Efficacy of Carboplatin Alone and in Combination with ABT888 in Intracranial Murine Models of BRCA-Mutated and BRCA-Wild-Type Triple-Negative Breast Cancer Molecular Cancer Therapeutics 14(4): 920-930
Rizzolo, P.; Silvestri, V.; Valentini, V.; Zelli, V.; Zanna, I.; Masala, G.; Bianchi, S.; Palli, D.; Ottini, L. 2018: Gene-specific methylation profiles in BRCA-mutation positive and BRCA-mutation negative male breast cancers Oncotarget 9(28): 19783-19792
Senkus-Konefka, E.; Domchek, S.M.; Im, S.A.; Xu, B.; Armstrong, A.; Masuda, N.; Delaloge, S.; Li, W.; Tung, N.; Conte, P.; Wu, W.; Goessl, C.; Runswick, S.; Robson, M. 2018: Subgroup analysis of olaparib monotherapy versus chemotherapy by hormone receptor and BRCA mutation status in patients with HER2-negative metastatic breast cancer and a germline BRCA mutation: OlympiAD European Journal of Cancer 92: S19-S20
Rizzolo, P.; Silvestri, V.; Licursi, V.; Navazio, A.S.; Valentini, V.; Zelli, V.; Bianchi, S.; Palli, D.; Fox, S.; Ottini, L. 2016: Methylome profiling of BRCA-positive and BRCA-negative MBCs European Journal of Cancer 61: S18-S19
Mitchell, R.; Buckingham, L.; Cobleigh, M.; Rotmensch, J.; Burgess, K.; Usha, L. 2018: Can chimerism explain breast/ovarian cancers in BRCA non-carriers from BRCA-positive families? Plos one 13(4): E0195497
Gunnala, V.; Irani, M.; Schattman, G.; Rosenwaks, Z. 2017: Brca mutation breast cancer patients show equivalent ovarian reserve and response to Ivf stimulation compared to Brca negative patients and other malignancies undergoing fertility preservation Fertility and Sterility 108(3): e83-e84
Aydin, F.; Akagun, T.; Yildiz, B.; Fidan, E.; Ozdemir, F.; Kavgaci, H. 2011: Clinicopathologic characteristics and BRCA-1/BRCA-2 mutations of Turkish patients with breast cancer Bratislavske Lekarske Listy 112(9): 521-523
Leung, M.F.K.L.; Leung, W.C. 1996: MRNA species of BRCA 1 and BRCA 2, the breast cancer susceptibility genes FASEB Journal 10(6): A1524
Stagnaro, S.; Caramel, S. 2013: BRCA-1 and BRCA-2 mutation bedside detection and breast cancer clinical primary prevention Frontiers in Genetics 4: 39